Vera Therapeutics (VERA) Institutional Ownership $21.80 +0.26 (+1.21%) Closing price 04:00 PM EasternExtended Trading$21.91 +0.11 (+0.52%) As of 05:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Vera Therapeutics (NASDAQ:VERA)CurrentInstitutional OwnershipPercentage99.21%Number ofInstitutional Buyers(last 12 months)138TotalInstitutional Inflows(last 12 months)$647.90MNumber ofInstitutional Sellers(last 12 months)66TotalInstitutional Outflows(last 12 months)$333.69M Get VERA Insider Trade Alerts Want to know when executives and insiders are buying or selling Vera Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data VERA Institutional Buying and Selling by Quarter Vera Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025Tower Research Capital LLC TRC 4,186$99K0.0%+192.9%0.007% 8/15/2025 Exome Asset Management LLC76,700$1.81M1.0%N/A0.120% 8/15/2025 Vestal Point Capital LP3,100,000$73.04M3.8%+24.0%4.861% 8/15/2025 Rafferty Asset Management LLC72,068$1.70M0.0%-15.1%0.113% 8/15/2025 Massar Capital Management LP16,000$377K0.3%N/A0.025% 8/15/2025 Hudson Bay Capital Management LP298,976$7.04M0.0%N/A0.469% 8/15/2025 BNP Paribas Financial Markets110,552$2.61M0.0%+499.4%0.173% 8/15/2025 Bank of America Corp DE394,280$9.29M0.0%+73.7%0.618% 8/15/2025 Ameriprise Financial Inc.17,388$410K0.0%-26.8%0.027% 8/14/2025 MPM Bioimpact LLC563,075$13.27M2.3%+35.4%0.883% Get the Latest News and Ratings for VERA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vera Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/14/2025 First Light Asset Management LLC562,981$13.26M1.7%-52.1%0.883% 8/14/2025 Commodore Capital LP800,000$18.85M1.3%-68.8%1.254% 8/14/2025 Raymond James Financial Inc.106,167$2.50M0.0%-8.5%0.166% 8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.31,721$744K0.0%+2.6%0.050% 8/14/2025 Armistice Capital LLC136,000$3.20M0.1%-54.7%0.213% 8/14/2025 The Manufacturers Life Insurance Company 139,864$3.30M0.0%-1.1%0.219% 8/14/2025 Squarepoint Ops LLC57,519$1.36M0.0%+232.0%0.090% 8/14/2025 Nebula Research & Development LLC19,634$463K0.0%N/A0.031% 8/14/2025 HighVista Strategies LLC40,473$954K0.4%-22.5%0.063% 8/14/2025 Soviero Asset Management LP30,000$707K0.4%N/A0.047% 8/14/2025 Qube Research & Technologies Ltd311,942$7.35M0.0%-9.5%0.489% 8/14/2025 AXA S.A.228,951$5.39M0.0%-6.8%0.359% 8/14/2025 Bollard Group LLC64,042$1.51M0.0%N/A0.100% 8/13/2025 Jump Financial LLC145,306$3.42M0.0%+285.2%0.228% 8/13/2025 Affinity Asset Advisors LLC545,000$12.84M1.8%-12.1%0.855% 8/13/2025 Marshall Wace LLP16,872$398K0.0%-91.1%0.026% 8/13/2025 Invesco Ltd.27,847$656K0.0%+2.0%0.044% 8/13/2025 Quantbot Technologies LP2,169$51K0.0%N/A0.003% 8/13/2025 New York State Common Retirement Fund17,929$422K0.0%-37.8%0.028% 8/13/2025 Schroder Investment Management Group372,749$8.78M0.0%-18.8%0.585% 8/13/2025 Virtus Investment Advisers LLC4,176$98K0.0%+14.8%0.007% 8/13/2025 Norges Bank188,422$4.44M0.0%N/A0.295% 8/13/2025 Quadrature Capital Ltd36,136$852K0.0%N/A0.057% 8/13/2025 Russell Investments Group Ltd.147,464$3.47M0.0%-3.6%0.231% 8/12/2025 XTX Topco Ltd57,919$1.37M0.1%+451.8%0.091% 8/12/2025 Ameritas Investment Partners Inc.5,254$124K0.0%+13.3%0.008% 8/12/2025 Prudential Financial Inc.62,037$1.46M0.0%-25.8%0.097% 8/12/2025 American Century Companies Inc.714,428$16.83M0.0%+89.3%1.120% 8/12/2025 Rhumbline Advisers75,070$1.77M0.0%+18.8%0.118% 8/12/2025 Legal & General Group Plc50,418$1.19M0.0%+1.7%0.079% Market Panic: Trump Just Dropped a Bomb on Your Stocks (Ad)tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.Don't wait for the next drop to wipe you out. Get the FREE Guide Before Markets Open Tomorrow8/12/2025 JPMorgan Chase & Co.310,547$7.32M0.0%+550.5%0.487% 8/12/2025 Handelsbanken Fonder AB16,600$391K0.0%+20.3%0.026% 8/11/2025 Knott David M Jr20,000$471K0.2%+100.0%0.031% 8/8/2025 Intech Investment Management LLC29,539$696K0.0%+3.1%0.046% 8/8/2025 Candriam S.C.A.296,941$7.00M0.0%-18.4%0.466% 8/8/2025 Police & Firemen s Retirement System of New Jersey11,870$280K0.0%+24.8%0.019% 8/8/2025 Geode Capital Management LLC1,294,958$30.51M0.0%+7.7%2.031% 8/8/2025 Quinn Opportunity Partners LLC19,000$448K0.0%N/A0.030% 8/7/2025 Profund Advisors LLC15,281$360K0.0%-13.4%0.024% 8/7/2025 Connor Clark & Lunn Investment Management Ltd.10,078$237K0.0%N/A0.016% 7/28/2025 TD Asset Management Inc200,274$4.72M0.0%-20.6%0.314% 7/23/2025 KLP Kapitalforvaltning AS8,500$200K0.0%-16.7%0.013% 7/21/2025 J. Safra Sarasin Holding AG29,567$697K0.0%N/A0.046% 7/21/2025 Platinum Investment Management Ltd.159,751$3.76M0.3%+14.7%0.251% 7/17/2025 GC Wealth Management RIA LLC13,567$320K0.0%N/A0.021% 7/16/2025 Perigon Wealth Management LLC10,406$245K0.0%N/A0.016% 7/15/2025 Fifth Third Bancorp4,330$102K0.0%N/A0.007% 6/18/2025 Voya Investment Management LLC627,357$15.07M0.0%-9.7%0.984% 5/29/2025 Rhumbline Advisers63,189$1.52M0.0%+7.9%0.099% 5/19/2025 Jane Street Group LLC41,578$999K0.0%-297.1%0.065% 5/19/2025 UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC98,013$2.35M0.0%+22.4%0.154% 5/16/2025 Woodline Partners LP1,000,849$24.04M0.2%-16.8%1.570% 5/16/2025 Goldman Sachs Group Inc.505,918$12.15M0.0%-8.8%0.793% 5/16/2025 Dynamic Technology Lab Private Ltd13,570$326K0.0%N/A0.021% 5/16/2025 Samlyn Capital LLC978,423$23.50M0.3%-41.1%1.535% 5/16/2025 Parkman Healthcare Partners LLC76,125$1.83M0.2%N/A0.119% 5/16/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.30,905$753K0.0%+7.7%0.048% 5/16/2025 EFG Asset Management North America Corp.109,281$2.62M0.4%+49.4%0.171% 5/16/2025 Cinctive Capital Management LP26,364$633K0.0%-76.8%0.041% 5/15/2025 First Light Asset Management LLC1,175,879$28.25M3.2%-6.8%1.845% 5/15/2025 Vestal Point Capital LP2,500,000$60.05M4.3%+132.6%3.922% 5/15/2025 MPM Bioimpact LLC415,719$9.99M1.7%+61.3%0.652% 5/15/2025 Armistice Capital LLC300,000$7.21M0.1%+68.3%0.471% 5/15/2025 Quarry LP2,500$60K0.0%+25.0%0.004% 5/15/2025 Magnetar Financial LLC16,982$408K0.0%N/A0.027% 5/15/2025 Siren L.L.C.747,216$17.95M1.0%-1.5%1.172% 5/15/2025 Trexquant Investment LP62,777$1.51M0.0%+187.1%0.098% 5/15/2025 Tri Locum Partners LP150,207$3.61M1.9%N/A0.236% 5/14/2025 Rafferty Asset Management LLC84,876$2.04M0.0%-3.2%0.133% 5/14/2025 Walleye Capital LLC198,659$4.77M0.0%N/A0.312% 5/14/2025 Jump Financial LLC37,719$906K0.0%N/A0.059% 5/14/2025 AlphaQuest LLC4,007$96K0.0%+404.7%0.006% 5/14/2025 Price T Rowe Associates Inc. MD4,754,832$114.21M0.0%+8.6%7.459% 5/14/2025 Candriam S.C.A.363,692$8.74M0.1%-0.6%0.571% 5/14/2025 T. Rowe Price Investment Management Inc.1,675,367$40.24M0.0%+18.4%2.628% 5/14/2025 Wellington Management Group LLP19,061$458K0.0%+5.8%0.030% 5/13/2025 Northern Trust Corp418,259$10.05M0.0%-8.1%0.656% 5/13/2025 Algert Global LLC70,010$1.68M0.0%+81.6%0.110% 5/13/2025 American Century Companies Inc.377,450$9.07M0.0%-12.0%0.592% 5/13/2025 Fox Run Management L.L.C.19,597$471K0.1%N/A0.031% Out of 18,347 Cryptocurrencies... This is the ONLY One (Ad)The Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should buy in this market, this token might just be it.Get the whole story on this "crypto market unicorn" right here.5/13/2025 Lord Abbett & CO. LLC148,530$3.57M0.0%-87.1%0.233% 5/13/2025 Russell Investments Group Ltd.152,918$3.67M0.0%+505.1%0.240% 5/12/2025 Knott David M Jr10,000$240K0.1%N/A0.016% 5/12/2025 Nuveen LLC156,882$3.77M0.0%N/A0.246% 5/12/2025 Invesco Ltd.27,297$656K0.0%+24.3%0.043% 5/9/2025 Deutsche Bank AG892,859$21.45M0.0%+10.2%1.401% 5/9/2025 Charles Schwab Investment Management Inc.424,940$10.21M0.0%-1.3%0.667% 5/9/2025 Vanguard Group Inc.2,918,423$70.10M0.0%-1.1%4.578% 5/8/2025 Decheng Capital LLC4,495$108K0.0%-91.0%0.007% 5/8/2025 Thornburg Investment Management Inc.66,572$1.60M0.0%+12.8%0.104% (Data available from 1/1/2016 forward) VERA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of VERA shares? During the previous two years, 193 institutional investors and hedge funds held shares of Vera Therapeutics. The most heavily invested institutionals were Avoro Capital Advisors LLC ($237.25M), FMR LLC ($129.12M), Price T Rowe Associates Inc. MD ($114.21M), Holocene Advisors LP ($86.39M), State Street Corp ($80.61M), Vestal Point Capital LP ($73.04M), and Vanguard Group Inc. ($70.10M).Learn more on Vera Therapeutics' institutional investors. What percentage of Vera Therapeutics' stock is owned by institutional investors? 99.21% of Vera Therapeutics' stock is owned by institutional investors. Learn more on VERA's institutional investor holdings. Which institutional investors have been buying Vera Therapeutics' stock? Of the 163 institutional investors that purchased Vera Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Avoro Capital Advisors LLC ($6.57M), Price T Rowe Associates Inc. MD ($3.21M), Vestal Point Capital LP ($3.10M), First Light Asset Management LLC ($1.56M), Schroder Investment Management Group ($1.12M), Lord Abbett & CO. LLC ($1.08M), and Vanguard Group Inc. ($1.02M). How much institutional buying is happening at Vera Therapeutics? Institutional investors have bought a total of 18,057,110 shares in the last 24 months. This purchase volume represents approximately $647.90M in transactions. Which of Vera Therapeutics' major shareholders have been selling company stock? Of the 66 institutional investors that sold Vera Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Commodore Capital LP ($1.76M), Point72 Asset Management L.P. ($1.06M), Lord Abbett & CO. LLC ($1.01M), Adage Capital Partners GP L.L.C. ($894K), Readystate Asset Management LP ($724.99K), First Light Asset Management LLC ($698.27K), and Samlyn Capital LLC ($683.80K). How much institutional selling is happening at Vera Therapeutics? Institutional investors have sold a total of 10,664,442 shares in the last 24 months. This volume of shares sold represents approximately $333.69M in transactions. Related Companies CRISPR Therapeutics Institutional Ownership Merus Institutional Ownership Viking Therapeutics Institutional Ownership TG Therapeutics Institutional Ownership ACADIA Pharmaceuticals Institutional Ownership Cytokinetics Institutional Ownership Akero Therapeutics Institutional Ownership Krystal Biotech Institutional Ownership ADMA Biologics Institutional Ownership Ascentage Pharma Group International Institutional Ownership This page (NASDAQ:VERA) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredGENIUS Act: Cancel Your Money?They said digital dollars were off the table. But with the GENIUS Act now federal law, private corporations—no...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vera Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vera Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access